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Abstract
Neurodegeneration is a major age-related pathology. Cognitive decline is characteristic of
patients with Alzheimer’s and related dementias and cancer patients after chemo- or radio-
therapies. A recently emerged driver of these and other age-related pathologies is cellular
senescence, a cell fate that entails a permanent cell cycle arrest and pro-inflammatory
senescence-associated secretory phenotype (SASP). Although there is a link between
inflammation and neurodegenerative diseases, there are many open questions regarding
how cellular senescence affects neurodegenerative pathologies. Among the various cell
types in the brain, astrocytes are the most abundant. Astrocytes have proliferative capacity
and are essential for neuron survival. Here, we investigated the phenotype of primary
human astrocytes made senescent by X-irradiation, and identified genes encoding gluta-
mate and potassium transporters as specifically downregulated upon senescence. This
down regulation led to neuronal cell death in co-culture assays. Unbiased RNA sequencing
of transcripts expressed by non-senescent and senescent astrocytes confirmed that gluta-
mate homeostasis pathway declines upon senescence. Our results suggest a key role for
cellular senescence, particularly in astrocytes, in excitotoxicity, which may lead to neurode-
generation including Alzheimer’s disease and related dementias.
Introduction
Cellular senescence entails a permanent cell cycle arrest, and is induced in response to several
types of stresses, including telomere shortening, DNA damage, oncogene activation and mito-
chondrial dysfunction [1]. Senescent cells are detected in culture and in vivo by several mark-
ers, including senescence-associated beta-galactosidase (SA-β-gal), upregulation of p16INK4a,
and the senescence-associated secretory phenotype (SASP), which includes the secretion of
High Mobility Group Box 1 (HMGB1), and downregulation of lamin B1 (LMNB1) [2]. Senes-
cence has been studied in several cell types, including fibroblasts, epithelial cells, muscle cells,
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hepatocytes and endothelial cells [3–9]. Importantly, previous studies have demonstrated a key
role for cellular senescence in aging and several age-related pathologies, including neurode-
generative diseases [2, 10–12]. However, relatively less is known about the potential role of
senescence in the brain.
Among the essential cell types in the brain, astrocytes are the most abundant population.
Astrocytes retain proliferative capacity, and their functions are crucial for neuron survival
[13]. Astrocytes are critical for mediating ion homeostasis, growth factor responses and neuro-
transmitter functions in the brain [14]. Previous studies showed that astrocyte dysfunction is
associated with multiple neurodegenerative diseases, including amyotrophic lateral sclerosis,
Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD) [15, 16].
Importantly, senescent astrocytes were identified in aged and AD brain tissue [11], and other
studies identified several factors that are responsible for inducing senescence in astrocytes [11,
15, 17]. These studies reported a link between an inflammatory environment and neurodegen-
erative diseases, but how astrocyte senescence might alter brain function in general remains
unclear.
Here, we characterize the senescent phenotype of human primary astrocytes. We used X-
irradiation to induce senescence in astrocytes, and real-time PCR, western blotting, ELISA and
cell-based assays to characterize the senescent phenotype of these astrocytes. We determined
that astrocytes undergo senescence after X-irradiation and exhibit several senescent markers,
similar to those reported for fibroblasts, including upregulation of p16INK4a and a SASP. Genes
that regulate glutamate homeostasis as well as potassium ion and water transport are essential
for normal astrocyte function. We detected a significant downregulation of several of these
genes upon astrocyte senescence. Using human astrocyte and neuron co-cultures, we further
established that senescent astrocytes affect the vulnerability of neurons to glutamate-induced
toxicity.
Materials and methods
Cell culture
Human primary astrocytes and culture media were obtained from ScienCell, and cells were
cultured as per the providers instructions. Purity of the astrocytes was confirmed by GFAP
staining (antibody from Sigma-Aldrich, #C9205). All experiments were performed at 3% oxy-
gen. Senescence was induced by X-ray irradiation (10 Gy).
X-irradiation
Cells were seeded in 4-well chambers, 6-well plates or 100-mm plates, and irradiated (IR) at
320 kv and 10 mA to achieve a dose of 10 Gy. After IR, fresh media were added. Mock-irradi-
ated cells were placed in the irradiator without power for an equivalent interval. Mock IR cells
were capable of proliferation, which, if kept in culture for 14 d, become confluent and show
false-positivity for some senescence markers. Irradiated cells, however, do not proliferate
throughout the 14 d course of the experiment and developed senescence characteristics. To
avoid false-positivity in control cells due to confluency, we processed control cells soon after
mock-irradiation.
SA-β-gal assay
SA-β-gal staining was performed using the Biovision kit (Prod# K320-250). Cells were plated
at 5,000 cells/cm2. SA-β-gal staining was performed 24–48 h after seeding, when cells are nor-
mally in log phase growth and 60%–70% confluent, to minimize false-positive staining. Cells
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were washed with PBS and fixed for 5 min with 2% formaldehyde–0.2% glutaraldehyde. After
another PBS wash, cells were incubated overnight at 37˚ C in staining solution. After washing
with PBS, a minimum of 400 cells counted. Positive (blue) cells are expressed as a percentage
of total cell number.
Real time-PCR
RNA was prepared using the Isolate II RNA mini kit (Bio-52073). RNA was reverse tran-
scribed (RT) using a Applied Biosystems (Carlsbad CA, USA) kit. Quantitative (q) RT-PCR
reactions were performed using the Universal Probe Library system (Roche, South San Fran-
cisco CA, USA). For quantification, the 2-ΔΔCp method was used to determine relative expres-
sion normalized to β-actin. The primer set details are in S1 Table.
Western blot analysis
Cells were washed with PBS, scraped in 200 μl 5% sodium dodecyl sulfate, sheared through a
needle and pelleted at 2,000 rpm for 5 min. Supernatants were assayed for protein concentra-
tion using the BCA protein assay kit (Pierce). Proteins were separated on 4–12% polyacryl-
amide gels (Biorad) and transferred to a PVDF membrane (Millipore). Membranes were
blocked in 5% milk powder and incubated with primary antibody for 2 h at room temperature
or overnight at 4˚ C. Membranes were washed with 1X tris buffered saline/tween-20 (TBS-T),
incubated with HRP conjugated secondary antibodies (Invitrogen), washed with TBS-T, and
detected using an Enhanced Electrochemoluminescence kit (GE Healthcare). Primary anti-
bodies were: EAAT1 (Abcam, #ab416), Kir4.1 (Alomone Labs, #APC-035), and actin (Sigma-
Aldrich, #A2228-200UL).
Co-culture assays
Astrocytes (Sciencell, Cat#1800) were made senescent by IR as described above. After 14 days,
they were treated with CMPTX-Red (Invitrogen, Cat# C34552), a fluorescent dye used to ren-
der all living astrocytes red. These cells were co-cultured with human fetal primary neurons.
The red astrocytes were easily distinguished from neurons in the co-cultures. On Day 1,
40,000 human neurons (Sciencell, Cat#1520) were seeded in 24-well plates on L-Poly lysine-
coated glass coverslips. On Day 3, CMPTX-Red labeled astrocytes were seeded (40,000/well)
with the neurons. On Day 4, co-cultures were treated with media containing either 10 mM glu-
tamate or control media. On Day 5, co-cultures were fixed and stained with DAPI. Fluores-
cence images were obtained to quantify surviving cells. CMPTX-Red+DAPI stained cells were
counted as astrocytes and DAPI-only stained (blue) cells were counted as neurons.
Enzyme-linked immunosorbent assays (ELISA) and AlphaLISA
ELISA kit to detect HMGB1 was from Neo Scientific (prod# HH0016) and used according to
the manufacturer’s protocol. AlphaLISA kit to detect IL-6 was from PerkinElmer (PerkinEl-
mer, #AL223F), used according to the manufacturer’s protocol. Conditioned media were pre-
pared by incubating non-senescent and senescent astrocytes in serum-free medium for 24 h.
Media were collected 14 d after irradiation, and ELISA results were normalized to cell number.
Immunofluorescence
Cells were washed in PBS, fixed in 4% paraformaldehyde, permeabilized with 0.5% Triton-X
100, washed, incubated in 10% goat serum for 1 h at RT, then incubated with a GFAP-Cy3
antibody (Sigma-Aldrich, #C9205) or HMGB1 antibody (Abcam, #ab18256) at 4˚ C overnight.
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After washing, slides were incubated with Alexa conjugated secondary antibodies for 30–45
min at RT. Nuclear DNA was stained with DAPI in mounting media (Vectasheild).
RNA-seq analysis
Human primary astrocytes from 6 different individuals were obtained from ScienCell (Cat
#1800, Lot #s 17320, 17158, 16091, 16492, 16700, 18709). Cells were seeded at 5,000/cm2. The
next day, cells were X-irradiated or mock-treated. Mock cells were cultured in serum-free
media for 24 h, and RNA was isolated. X-irradiated cells were given complete media for 13
days, then cultured in serum-free media for 24 h. 14 days after X-irradiation, RNA was iso-
lated. RNA quality and quantity was determined, then RNA samples were prepared using the
Illumina Truseq kit and sent to BGI Americas Corporation for sequencing on Illumina
HiSeq4000. In parallel, RNA was reverse transcribed and qRT-PCR reactions were performed
for p16INK4a, IL-6 and IL-8.
Statistical analyses
Error bars indicate mean ± s.e.m or SD. Significance of differences in mean values was deter-
mined using the two-tailed unpaired Student’s t test or one-way ANOVA unless otherwise
mentioned. P<0.05 was considered significant. Each experiment was reproduced at least twice
independently. SA-β-gal was assessed blinded.
Results
Irradiation induces senescence and a SASP in human primary astrocytes
To investigate the senescent phenotype of astrocytes, we used human primary astrocytes as
described in Materials and Methods. Astrocytes purity was at least 95%, as assessed by GFAP-pos-
itivity (Fig 1A). IMR-90 fibroblasts were used as negative control for GFAP staining. Senescence
was induced by ionizing X-irradiation (IR, 10 Gy) and mock irradiation was used as a control.
RNA and conditioned media (CM) from non-senescent (NS) and senescence (SEN) cells were
collected and fixed for staining at Day 2 and Day 14 of treatment, respectively (S1 Fig). SA-β-gal
staining [18] showed that 97% of SEN astrocytes cells were positive compared to NS controls (Fig
1B). We also tested the cells several other markers of senescence. By RNA analysis, p16INK4a was
upregulated in SEN cells, whereas LMNB1 [19] was downregulated in SEN cells (Fig 1C). We also
investigated the senescence-associated secretory phenotype (SASP), including IL-6, IL-8 and
CXCL-1 [20], all of which were upregulated in SEN compared to NS cells (Fig 1D).
To determine senescence markers at the protein level, we performed immunofluorescence
(IF) and ELISA for HMGB1 for NS and SEN samples. HMGB1 is a non-histone nuclear pro-
tein, and is lost from the nuclei and secreted as a damage-associated molecular pattern
(DAMP) by SEN cells [21]. SEN, but not NS, astrocytes lost nuclear HMGB1 (Fig 1E).
HMGB1 ELISAs on CM from NS and SEN astrocytes confirmed that HMGB1 was secreted by
SEN but not NS cells (Fig 1F). AlphaLISA for IL-6 on CM from NS and SEN cells showed that
IL-6 secretion was highly upregulated in SEN astrocytes versus NS cells (Fig 1G). Thus, X-irra-
diation-induced senescence of human astrocytes induced major senescence characteristics
described for human fibroblasts [22].
Senescence downregulates expression of genes crucial for astrocyte
function
Astrocytes are critical for the efficient uptake of excess glutamate from the synaptic cleft [23].
Astrocytes maintain glutamate, glutamine, potassium and water homeostasis in the brain. We
Senescence and glutamate toxicity
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Fig 1. Human primary astrocytes undergo senescence and express a SASP upon X-irradiation. (a) Immunofluorescence staining
for the astrocyte marker GFAP was performed on primary human astrocytes and IMR-90 fibroblasts. (b) Cellular senescence (SEN)
was induced in astrocytes by X-irradiation (IR). Fourteen days after IR, SA-β-gal staining was performed on non-senescent (NS)
control cells and SEN cells. Quantification is shown in the right panel. (c-d) Real-time PCR was performed on RNA samples from NS
and SEN cells. (c) shows the expression of p16INK4a (left) and LMNB1 (right). (d) shows the expression of three SASP factors, IL-6, IL-
8 and CXCL-1. (e) High mobility group box 1 (HMGB1) immunofluorescence staining was performed on NS and SEN astrocytes.
Quantification is shown in the right panel (n = 3, where n = experimental replicates). (f-g) ELISAs and AlphaLISAs were performed
Senescence and glutamate toxicity
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therefore examined how senescence affects the expression of genes that regulate these pro-
cesses in astrocytes, including Excitatory Amino Acid Transporters 1 (EAAT1) and 2
(EAAT2) (S2 Fig; [14]), potassium transporter Kir4.1 and water transporter AQP4 (also
required for efficient glutamate transport [24]). By real-time PCR, the expression of all these
genes were downregulated in SEN cells compared to NS astrocytes (Fig 2A).
To determine whether the downregulation of these genes was transient or persistent, we
performed a time course (Day 7, 10, 14 and 21 after IR). SEN cells showed positive SA-β-gal
staining compared to NS cells, and the staining in SEN cells increased with time, reaching a
plateau at Day 10 (S2B Fig). RT-PCR results showed that p16INK4a mRNA levels also gradually
increased in SEN samples (S2C Fig). Conversely, levels of EAAT1, EAAT2 and Kir4.1 mRNA
gradually declined with time, reaching their lowest levels after 14 days (Fig 2B–2D).
We also extracted proteins from NS and SEN cells 14 d after irradiation. Western analysis
showed that expression of the two transporters most significantly downregulated at the mRNA
level, EAAT1 and Kir4.1, also decreased at the protein level in SEN cells compared to NS cells
(Fig 2E).
These results demonstrate that senescence not only induces inflammation in astrocytes, but
also affects the expression of critical functional genes that modulate excitotoxicity. Using RNA
sequencing (RNA-seq), we next attempted to confirm whether senescence induced by X-irra-
diation could indeed affect these specific pathways in astrocytes.
RNA-seq confirms a senescence-specific deficiency in glutamate
homeostasis
We used RNA-seq to compare the transcriptomes of NS and SEN astrocytes. We used astro-
cytes from 6 different human embryos. For SEN cells, we extracted RNA 14 days after X-irra-
diation. For NS cells, RNA we extracted RNA after 2 days of culture. A detailed protocol is
described in Materials and Methods. Before sending the samples for sequencing, we confirmed
that the senescence markers p16INK3a and SASP factors IL-6 and IL-8 were elevated in SEN,
compared to NS, samples (Fig 3A).
RNA-seq produced 20–25 M pair-ended, 2x150 base-long reads per sample. Trimming and
filtering low quality sequences using Trimmomatics [25] resulted with 18–22 M high quality
paired-end reads, which we aligned to the NCBI GRCH38 human reference genome, using
TopHat2 software [26], mapping rate 89%-90% across samples (S2 Table). We used the Tux-
edo protocol [27] to calculate statistical significance of differential expression.
The results showed expected changes in senescence markers. For example, p16INK4a mRNA
was significantly increased in SEN samples (Fig 3B, left panel), while LMNB1 mRNA was sig-
nificantly decreased (Fig 3B, center panel), and mRNAs encoding SASP factors IL-6, IL-8 and
CXCL-1 increased (Fig 3B, right panel). Hierarchical clustering using the Jensen-Shannon dis-
tance metric showed greater similarity among NS samples (NS1 to NS6) and among SEN sam-
ples (SEN1 to SEN6) (Fig 3C).
Using CuffDiff [27], we identified 5,809 significantly differentially expressed genes (SDE),
of which 2,915 were significantly upregulated (SUR) and 2,894 were significantly downregu-
lated (SDR) by senescence (S3 Table). We performed disease enrichment analysis on the 2,915
significantly upregulated genes and we found that these genes fell into categories such as
using conditioned media (CM) collected from NS and SEN cells; (f) shows HMGB1 ELISA results (n = 2, where n = experimental
replicates), and (g) shows IL-6 AlphaLISA results (n = 3, where n = experimental replicates). For (b-d) (n = 2), shown are
representative results from 3 independent experiments. For (b-g): �p<0.05, ��p<0.02, ���p<0.001, ����p<0.0001 (unpaired t test).
https://doi.org/10.1371/journal.pone.0227887.g001
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Fig 2. Senescence in astrocytes downregulates genes that modulate excitotoxicity. (a) Real-time PCR was performed for EAAT1,
EAAT2, Kir4.1, and AQP4 mRNA using RNA samples from NS and SEN astrocytes. (b-d) Time course experiments of astrocytes
after IR. Samples were collected days 7, 10, 14, 21 after treatment. Real-time PCR was performed on NS and SEN samples at the
indicated times; (b) corresponds to EAAT1 gene expression, (c) corresponds to EAAT2 gene expression, and (d) corresponds to
Kir4.1 gene expression. (e) Western blotting was performed using protein extracts from NS and SEN 14 days after X-irradiation.
Antibodies against EAAT1 and Kir4.1 were used. For (a-e) (n = 2), shown are the representative results from 2 independent
experiments. For (a): �p<0.05, ��p<0.02, ���p<0.001 (unpaired t test). For (b-d): ��p<0.02, ���p<0.001, ����p<0.0001 (ordinary
one-way ANOVA).
https://doi.org/10.1371/journal.pone.0227887.g002
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Fig 3. RNA-seq data reveal genes regulated in astrocytes upon senescence induction. (a) RNA extracted from SEN astrocytes
corresponding to 6 different human cell strains was compared to RNA extracted from NS samples. p16INK4a and SASP factors (IL-6 and IL-8)
were analyzed by real-time PCR. (b) RNA-seq results (presented as Fragments Per Kilobase Million or FPKM) for the expression of various
genes, i.e., p16INK4a (left panel), LMNB1 (center panel) and IL-6, IL-8, CXCL-1 (right panel) were compared between NS and SEN samples.
(c) Hierarchical clustering using the Jensen-Shannon distance metric was used to determine the similarity within the 6 NS samples and
within the 6 SEN samples. (d) A heatmap based on FPKM of Transporter-associated Astrocyte Enriched Genes (TAEG) in all the NS and
SEN samples is shown. For (a), n = 2s. For (b), n = 3. For (a, b): �p<0.05, ��p<0.02, ���p<0.001, ����p<0.0001 (unpaired t test).
https://doi.org/10.1371/journal.pone.0227887.g003
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cancer, infectious disease or AD (S4 Table). Disease enrichment analysis on the 2,894 signifi-
cantly downregulated genes indicated that these genes fell into categories such as neurological
disease or cancer (S5 Table).
To identify astrocyte-specific processes affected by senescence, we utilized the publicly
available dataset from NetWork Glia (http://www.networkglia.eu/en/astrocyte), which consists
of astrocyte-enriched genes from 3 published datasets (enrichment is defined as fold
change� log2 with a FDR� 0.05). Of the 254 astrocyte-enriched genes with at least one anno-
tated GO term, 32 genes were SUR and 91 were SDR by SEN astrocytes in our RNA-seq results
(SUR-AE, SDR-AE respectively).
Using DAVID [28], SUR-AE genes with an enrichment score of 4.1, were categorized in the
‘Extra-cellular space’ and ‘Secreted’ terms, and included the following 13 genes: VCAM1,
MASP1, CXCL14, APOE, IL18, CTSO, CHI3L1, MFGE8, IGFBP2, FGF1, GHR, HAPLN1,
SDC4. For SDR-AE genes, the first cluster, with an enrichment score of 2.4, was in the
‘Amino-acid biosynthesis‘ and ‘Biosynthesis of antibiotics’ categories, and included the follow-
ing 9 genes: ACSS1, CTH, ALDOC, PHGDH, AASS, PSAT1, ACSS2, CBS, MAOB. The second
cluster, with an enrichment score of 2.27, consisted of the ‘Transporter activity’ and ‘Transport’
terms, and included the following 18 genes: SLC13A5, MLC1, ATP1B2, SLC15A2, FADS1,
AQP4, FADS2, SPIRE1, SELENBP1, ATP1A2, DBI, SFXN5, SLC1A2, SLC1A3, TTYH1,
FABP7, RLBP1, FABP5. The most enriched term for SDR-AE genes, with a FDR = 0.0015, was
‘Negative regulation of neuron differentiation’ with the following 7 significantly down regulated
genes: HES5, SOX2, PAX6, ID4, GLI3, NR2E1, GPR37L1.
Based on the results in Fig 2, we assembled a list of 36 Transporter-associated Astrocyte
Enriched Genes (TAEG) by including genes in the astrocyte-enriched dataset associated with
any term containing the word ‘Transporter’. We then perform gene-set enrichment analysis on
TAEG; this permutation analysis provided p-values of 0.08 (probability of drawing a random
set of genes that more downregulated in SEN cells than the TAEG). Fig 3D shows a heatmap
based on Fragments Per Kilobase of transcript per Million mapped reads (FPKM) of TAEG in
NS and SEN samples. Notably, SLC1A3 corresponds to EAAT1 and SLC1A2 corresponds to
EAAT2.
This analysis revealed a significant downregulation of the expression of several transporters
(EAAT1, EAAT2 and Kir4.1) in all 6 SEN samples compared to NS samples, which we con-
firmed again by real-time PCR (S3 Fig). As an unbiased validation of our data Fig 2, these
results show that senescence not only induces astrocytes to express inflammatory genes, but
also reduces the expression of genes that modulate excitotoxicity.
Senescent astrocytes confer vulnerability to glutamate toxicity on neurons
Thus, we next asked whether SEN-associated downregulation of genes encoding glutamate
and potassium transporters affects glutamate uptake by astrocytes, and consequently the func-
tion of neurons. First, we applied glutamate to NS and SEN astrocytes to determine a concen-
tration that was non-toxic to the astrocytes. At 10 mM, glutamate did not trigger any
significant morphological changes in astrocytes compared to 0 mM, nor did it trigger any cell
death (S4A Fig), whereas this concentration induced death of pure neuronal cultures (S4B Fig)
(at 20 mM, there was substantial cell death observed in both NS and SEN astrocyte cultures).
Therefore, for astrocyte/neuron co-culture experiments, we used a glutamate concentration of
10 mM.
We seeded cells for co-culture as described in Materials and Methods. After 24 h of co-cul-
ture in the absence of glutamate, neurons survived, whether cultured with NS or SEN cells.
However, in the presence of 10 mM glutamate, neurons showed signs of cell death, but only
Senescence and glutamate toxicity
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when co-cultured with SEN astrocytes. No glutamate-dependent neuronal cell death was evi-
dent with neurons were cultured with glutamate and NS astrocytes. To quantify neuronal cell
survival in co-culture assays, we pre-labeled the astrocytes with CMPTX-red. We initially
tested the neuronal marker Beta-Tubulin III to distinguish neurons from astrocytes, but fetal
astrocytes also express this marker, as reported [29].
We co-cultured neurons and astrocytes in the absence (Fig 4A and 4B) or presence (Fig 4C
and 4D) of 10 mM glutamate. After 24 h, the cells were fixed and nuclei were stained with
DAPI. Thus, red+DAPI staining identified astrocytes, whereas DAPI only staining identified
neurons. In the presence of 10 mM of glutamate, almost 50% of the neurons died when co-cul-
tured with SEN astrocytes (Fig 4D; compare Lane 2 to Lane 1). On the contrary, neurons
showed no sign of cell death in the presence of glutamate when co-cultured with NS astrocytes.
We conclude that SEN astrocytes do not take up glutamate efficiently, which leads to neuronal
cell death.
Fig 4. Increased neuronal death in co-cultures with SEN astrocytes dependent on glutamate. (a-b) Neurons (only DAPI-stained cells) were
co-cultured with NS or SEN astrocytes (CMPTX-red + DAPI-stained cells) in neuronal media. The co-cultures were treated for 24 h with control
media without glutamate. In (a) we show the fluorescent images, and in (b) the cell quantification. (c-d) Neurons were also co-cultured with NS
or SEN astrocytes in neuronal media. However, here co-cultures were treated for 24 h with media containing 10 mM glutamate. In (c) we show
the fluorescent images, and in (d) the cell quantification. Lane 1: surviving neurons (NS astrocytes + neurons co-cultures). Lane 2: surviving
neurons (SEN astrocytes + neurons co-cultures). Lane 3: surviving astrocytes (NS astrocytes + neurons co-cultures). Lane 4: surviving astrocytes
(SEN astrocytes + neurons co-cultures). For (b, d) (n = 4, where n = experimental replicates): ns = not significant, �p<0.05, ��p<0.02 (unpaired t
test).
https://doi.org/10.1371/journal.pone.0227887.g004
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Discussion
Cellular senescence is a pleiotropic cell fate that prevents cancer in early life, but can also pro-
mote age-related diseases, including cancer, during aging, largely by producing pro-inflamma-
tory SASP factors [20, 30]. Most of our understanding of the SASP derives from studies of
human fibroblasts [22]. Recently, Jeon et al. showed that irradiation caused glioblastoma
(GBM) cells, the most aggressive type of brain cancer, to undergo senescence [31, 32]. These
senescent GBM cells secreted a SASP and promoted tumor cell growth.
Here, we show that human primary astrocytes also undergo senescence upon irradiation
and manifest some of the classical features of senescence, including a pro-inflammatory SASP.
We therefore investigated how non-cancerous senescent astrocytes might affect the brain
microenvironment. We reasoned that pro-inflammatory factors secreted by astrocytes could
not only promote brain cancer, but could also contribute to neurodegeneration in diseases
such as AD and PD [33, 34]. Moreover, astrocyte senescence has been observed in AD patients
or upon irradiation [11, 12, 34, 35]. Eliminating senescent cells could hold therapeutic promise
for halting neurodegeneration. Indeed, depleting senescent astrocytes abrogates the develop-
ment of neurodegenerative phenotypes associated with systemic exposure of the herbicide
paraquat [36].
In addition to inflammatory factors, astrocytes play a critical role in neuronal survival [37–
41]. Here, we show that senescence compromises astrocyte-specific functions, including gluta-
mate and potassium transport. Glutamate and potassium transporters are important for main-
taining the appropriate amount of glutamate in the brain [42]. Excessive glutamate causes
neuronal cell death (glutamate excitotoxicity). Glutamate toxicity has been studied in various
neurodegenerative diseases, including AD, PD, HD, amyotrophic lateral sclerosis (ALS) and
epilepsy [16, 43, 44]. Glutamate binds to N-methyl-D-aspartate (NMDA) subtype of glutamate
receptors. Almost all neurons in the CNS carry NMDA receptors, and excessive activation of
these receptors leads to excitotoxicity.
In AD, amyloid β-related peptides increase glutamate release and inhibit glutamate uptake
by astrocytes, leading to excitotoxicity [43, 45, 46]. Our recent preliminary results on the hip-
pocampus of the AD mouse model J20 suggest that senescence is induced in this model, creat-
ing an inflammatory environment in the brain. We recently found a correlation between the
induction of senescence and downregulation of glutamate and potassium transporters in the
hippocampus, suggesting that senescence might promote glutamate toxicity in AD.
Several studies identified key genes that likely contribute to AD. These studies used AD
patient samples and mouse models. In human patient samples, astrocytes are neuroprotective
when glutamate transporters are highly expressed [47]. Glutamate transporter expression var-
ies among mouse models of AD and depends on the brain region. For example, the triple
transgenic (3xTg-AD) mouse shows no change in glutamate transporter expression in cortex,
but decreased expression in hippocampus [48, 49]. Finally, several therapies, such as Riluzole
and Ceftriaxone, designed to increase glutamate transporters improve memory function in
AD humans and models [48, 50]. Our results on glutamate transporter expression and gluta-
mate toxicity are consistent with these studies.
Interestingly, in addition to the downregulation in glutamate and potassium transport in
SEN astrocytes, our RNA-seq data identified two genes, GJA1 and APOE, as upregulated in
SEN compared to NS cells. GJA1 encodes the gap junction protein alpha 1 (also called con-
nexin 43) that participates in forming channels between cells. Elevated GJA1 immunoreactiv-
ity was found at sites of amyloid plaques in AD [51]. APOE encodes apolipoprotein E, which
participates in fat metabolism and plaque formation in the brain, and is important in AD since
the APOE4 allele predisposes to late-onset familial AD [52, 53]. The increased expression of
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these two proteins in senescent astrocytes may exacerbate the pathological microenvironment
of the brain in patients with AD.
Excitotoxicity has been documented in other neurodegenerative diseases [24, 54, 55]. Downre-
gulation of glutamate transporters in astrocytes has been reported in epilepsy and ALS [44]. More-
over, decreased glutamate transporters are thought to contribute to the progressively disturbed
glutamate homeostasis in the brains of patients with HD [24, 56–58]. Potassium transporters are
also necessary for efficient glutamate uptake by astrocytes and preventing excitotoxicity [24]. Our
data show that senescent astrocytes display a strong downregulation of the potassium transporter,
Kir4.1. Kir4.1 deficiency can contribute to excitotoxicity and neuronal dysfunction, and can have
detrimental effects in HD [56]. None of these disease conditions (other than AD) have been tested
for the potential presence and role of senescent cells. Finally, our results show that senescent astro-
cytes downregulate the water transport channel AQP4. Further experiments will be needed in
order to investigate the effects of AQP4 deficiency in astrocytes.
Interestingly, senescence was induced in human fetal astrocytes by transient oxidative stress
[59]. Although genes involved in neuronal and glial development and differentiation were
shown to be downregulated, changes in transporter expression were not reported. However,
from their differential expression analysis, it was clear that the major transporters identified in
our study (EAAT1, EAAT2 and Kir4.1) were also significantly downregulated in astrocytes
induced to senescence by oxidative stress. These data suggest that different means of senes-
cence induction can trigger similar effects in human astrocytes. However, downregulation of
the glutamate homeostasis gene family appears to be specific to astrocytes. We also tested
EAAT1, EAAT2 and Kir4.1 expression in senescent human fibroblasts, and found that these
genes were either not expressed or upregulated upon senescence induction.
For the treatment of AD and ALS, there are currently a few FDA-approved drugs that
inhibit NMDA receptors and are anti-excitotoxic. Among these drugs are Memantine and
Riluzole [60–62]. If senescent cells, detected in neurodegenerative diseases, are found to con-
tribute to excitotoxicity, targeted removal of these cells could open new avenues for treatment.
Senolytics are a new class of drugs used to remove senescent cells, and compounds such as
ABT263 have been shown to clear senescent cells efficiently and rejuvenate stem cells in aged
mouse tissues [63]. This type of compounds could be used to develop novel therapeutic
approaches for neurodegenerative diseases such as AD.
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